| 1 | <scp>CAR</scp> T cell‐driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma | 4.7 | 1 | Citations (PDF) |
| 2 | Microbiota-Associated HAF-EVs Regulate Monocytes by Triggering or Inhibiting Inflammasome Activation | 4.5 | 10 | Citations (PDF) |
| 3 | Extracellular Vesicles in Aging: An Emerging Hallmark? | 4.8 | 41 | Citations (PDF) |
| 4 | Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia | 3.0 | 8 | Citations (PDF) |
| 5 | Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy | 9.1 | 16 | Citations (PDF) |
| 6 | T cell fat catabolism: A novel target for kynurenine? | 9.0 | 3 | Citations (PDF) |
| 7 | Amniotic fluid stem cell‐derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP‐1 cells | 0.7 | 16 | Citations (PDF) |
| 8 | Liver gene therapy with intein‐mediated F8
<i>trans</i>
‐splicing corrects mouse haemophilia A | 7.2 | 12 | Citations (PDF) |
| 9 | Liver-Directed Adeno-Associated Virus–Mediated Gene Therapy for Mucopolysaccharidosis Type VI | 10.9 | 23 | Citations (PDF) |
| 10 | Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication | 16.7 | 94 | Citations (PDF) |
| 11 | The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions | 4.5 | 53 | Citations (PDF) |
| 12 | Novel mutations in the <i>WFS1</i> gene are associated with Wolfram syndrome and systemic inflammation | 3.1 | 32 | Citations (PDF) |
| 13 | Author response: Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism 2021, , | | 3 | Citations (PDF) |
| 14 | Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy | 4.5 | 49 | Citations (PDF) |
| 15 | 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine | 14.2 | 54 | Citations (PDF) |
| 16 | Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19 | 2.8 | 22 | Citations (PDF) |
| 17 | Aspergillus fumigatus tryptophan metabolic route differently affects host immunity | 6.2 | 30 | Citations (PDF) |
| 18 | Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs) | 5.5 | 43 | Citations (PDF) |
| 19 | HOPS/Tmub1 involvement in the NF-kB-mediated inflammatory response through the modulation of TRAF6 | 8.5 | 18 | Citations (PDF) |
| 20 | Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?Drugs, 2020, 80, 1383-1396 | 9.1 | 104 | Citations (PDF) |
| 21 | Editorial: Immunomodulatory Roles of Tryptophan Metabolites in Inflammation and Cancer | 5.0 | 25 | Citations (PDF) |
| 22 | Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor | 6.9 | 38 | Citations (PDF) |
| 23 | Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brain | 2.3 | 29 | Citations (PDF) |
| 24 | Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation | 7.5 | 78 | Citations (PDF) |
| 25 | HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53‐dependent mitochondrial apoptosis | 5.2 | 27 | Citations (PDF) |
| 26 | Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1 | 5.0 | 3 | Citations (PDF) |
| 27 | Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine | 5.0 | 31 | Citations (PDF) |
| 28 | Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 | 5.2 | 32 | Citations (PDF) |
| 29 | The cellular prion protein beyond prion diseases | 1.6 | 19 | Citations (PDF) |
| 30 | Experimental evidences on the role of silica nanoparticles surface morphology on the loading, release and activity of three proteins | 4.7 | 9 | Citations (PDF) |
| 31 | Toll‐like receptors as novel therapeutic targets for herpes simplex virus infection | 7.1 | 28 | Citations (PDF) |
| 32 | Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation | 5.5 | 21 | Citations (PDF) |
| 33 | Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells | 5.0 | 70 | Citations (PDF) |
| 34 | <scp>IL</scp>‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 | 4.1 | 10 | Citations (PDF) |
| 35 | Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond | 39.5 | 1,284 | Citations (PDF) |
| 36 | Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence 2019, 196, 105-116 | | 107 | Citations (PDF) |
| 37 | 38<sup>th</sup> International Winter-Workshop Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics Innsbruck, February 26<sup>th</sup> – March 1<sup>st</sup>, 2019 | 0.6 | 1 | Citations (PDF) |
| 38 | Targeting metabotropic glutamate receptors for the treatment of neuroinflammation | 4.2 | 42 | Citations (PDF) |
| 39 | Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 | 4.6 | 6 | Citations (PDF) |
| 40 | IL‐35, a hallmark of immune‐regulation in cancer progression, chronic infections and inflammatory diseases | 4.5 | 68 | Citations (PDF) |
| 41 | Binding Mode and Structure–Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist | 3.2 | 24 | Citations (PDF) |
| 42 | Nrf2 as regulator of innate immunity: A molecular Swiss army knife! | 12.5 | 171 | Citations (PDF) |
| 43 | Autologous Cell Therapy for Vascular Regeneration: The Role of Proangiogenic Cells | 2.5 | 13 | Citations (PDF) |
| 44 | Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration | 14.2 | 233 | Citations (PDF) |
| 45 | S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid–derived stem cells | 4.4 | 21 | Citations (PDF) |
| 46 | Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes | 5.5 | 60 | Citations (PDF) |
| 47 | Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal StudyBlood, 2018, 132, 3781-3781 | 1.0 | 0 | Citations (PDF) |
| 48 | PCSK9 at the crossroad of cholesterol metabolism and immune function during infections | 4.2 | 69 | Citations (PDF) |
| 49 | A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells | 16.7 | 313 | Citations (PDF) |
| 50 | Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis | 36.5 | 97 | Citations (PDF) |
| 51 | Interaction of 7-Alkoxycoumarins with the Aryl Hydrocarbon Receptor | 3.7 | 11 | Citations (PDF) |
| 52 | Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1 | 2.3 | 21 | Citations (PDF) |
| 53 | Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1 | 4.1 | 67 | Citations (PDF) |
| 54 | The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes | 5.0 | 34 | Citations (PDF) |
| 55 | CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis | 3.6 | 8 | Citations (PDF) |
| 56 | Aryl Hydrocarbon Receptor: An Environmental Sensor in Control of Allergy Outcomes | 0.0 | 2 | Citations (PDF) |
| 57 | IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis | 2.5 | 21 | Citations (PDF) |
| 58 | Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial | 3.7 | 35 | Citations (PDF) |
| 59 | Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus | 2.9 | 21 | Citations (PDF) |
| 60 | Differential inflammatory phenotypes upon genetic or pharmacologic inactivation of indoleamine dioxygenase in experimental steatohepatitis | 1.1 | 0 | Citations (PDF) |
| 61 | Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells | 4.5 | 32 | Citations (PDF) |
| 62 | Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype | 4.2 | 89 | Citations (PDF) |
| 63 | Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice | 12.3 | 30 | Citations (PDF) |
| 64 | Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan DerivativesBlood, 2016, 128, 2563-2563 | 1.0 | 0 | Citations (PDF) |
| 65 | Stem cells from human amniotic fluid exert immunoregulatory function <i>via</i> secreted indoleamine 2,3‐dioxygenase1 | 4.1 | 53 | Citations (PDF) |
| 66 | Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice | 1.4 | 9 | Citations (PDF) |
| 67 | Long‐term stability, functional competence, and safety of microencapsulated specific pathogen‐free neonatal porcine Sertoli cells: a potential product for cell transplant therapy | 2.9 | 28 | Citations (PDF) |
| 68 | Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers | 2.5 | 86 | Citations (PDF) |
| 69 | Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ | 2.0 | 139 | Citations (PDF) |
| 70 | In vitro cadmium effects on ECM gene expression in human bronchial epithelial cells | 3.5 | 24 | Citations (PDF) |
| 71 | The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen‐Activated Protein Kinase Inhibitors | 3.2 | 17 | Citations (PDF) |
| 72 | A NOVEL ROLE FOR THE KYNURENINE PATHWAY IN EXPERIMENTAL STEATOHEPATITIS | 1.1 | 5 | Citations (PDF) |
| 73 | Comparative proteomic analysis of two distinct stem-cell populations from human amniotic fluid | 2.8 | 7 | Citations (PDF) |
| 74 | Involvement of the IDO-1 pathway in experimental NASH | 1.1 | 0 | Citations (PDF) |
| 75 | LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism | 1.1 | 33 | Citations (PDF) |
| 76 | IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII | 9.1 | 43 | Citations (PDF) |
| 77 | Distinct and complementary roles for <i>Aspergillus fumigatus</i>‐specific Tr1 and Foxp3<sup>+</sup> regulatory T cells in humans and mice | 2.7 | 22 | Citations (PDF) |
| 78 | Forced <scp>IDO</scp>1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes | 4.1 | 56 | Citations (PDF) |
| 79 | Ligand Binding and Functional Selectivity of <scp>l</scp>-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR) | 5.0 | 46 | Citations (PDF) |
| 80 | Tryptophan Feeding of the IDO1-AhR Axis in Host–Microbial Symbiosis | 5.0 | 73 | Citations (PDF) |
| 81 | AhR-Mediated, Non-Genomic Modulation of IDO1 Function | 5.0 | 43 | Citations (PDF) |
| 82 | Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice | 4.5 | 52 | Citations (PDF) |
| 83 | Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment | 4.5 | 79 | Citations (PDF) |
| 84 | Aryl hydrocarbon receptor control of a disease tolerance defence pathway | 34.3 | 677 | Citations (PDF) |
| 85 | On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness | 4.6 | 9 | Citations (PDF) |
| 86 | High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway | 14.2 | 121 | Citations (PDF) |
| 87 | Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22 | 16.7 | 2,138 | Citations (PDF) |
| 88 | Th17/Treg Imbalance in Murine Cystic Fibrosis Is Linked to Indoleamine 2,3-Dioxygenase Deficiency but Corrected by Kynurenines | 9.3 | 97 | Citations (PDF) |
| 89 | Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy | 3.5 | 13 | Citations (PDF) |
| 90 | Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival | 0.6 | 65 | Citations (PDF) |
| 91 | A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression | 0.6 | 23 | Citations (PDF) |
| 92 | TLR3 essentially promotes protective class I–restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patientsBlood, 2012, 119, 967-977 | 1.0 | 132 | Citations (PDF) |
| 93 | Targeting metabotropic glutamate receptors in neuroimmune communication | 4.5 | 19 | Citations (PDF) |
| 94 | Indoleamine 2,3‐dioxygenase: From catalyst to signaling function | 3.4 | 165 | Citations (PDF) |
| 95 | Jack of all trades: thymosin α1 and its pleiotropy | 4.6 | 49 | Citations (PDF) |
| 96 | Prolongation of skin allograft survival in rats by the transplantation of microencapsulated xenogeneic neonatal porcine Sertoli cells | 12.3 | 28 | Citations (PDF) |
| 97 | Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells | 24.9 | 641 | Citations (PDF) |
| 98 | Using an Ancient Tool for Igniting and Propagating Immune Tolerance: IDO as an Inducer and Amplifier of Regulatory T Cell Functions | 2.5 | 54 | Citations (PDF) |
| 99 | Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study | 1.0 | 1 | Citations (PDF) |
| 100 | Xenograft of Microencapsulated Sertoli Cells Reverses T1DM in NOD Mice by Inducing Neogenesis of Beta-Cells | 0.8 | 18 | Citations (PDF) |
| 101 | Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8<sup>+</sup> Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3) | 3.8 | 26 | Citations (PDF) |
| 102 | Thymosin α1: the regulator of regulators? | 4.6 | 40 | Citations (PDF) |
| 103 | Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation | 36.5 | 150 | Citations (PDF) |
| 104 | IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis | 0.6 | 331 | Citations (PDF) |
| 105 | IL-22 defines a novel immune pathway of antifungal resistance | 7.0 | 267 | Citations (PDF) |
| 106 | Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction | 14.9 | 334 | Citations (PDF) |
| 107 | Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to<i>Aspergillus</i> | 0.6 | 25 | Citations (PDF) |
| 108 | IDO Mediates TLR9-Driven Protection from Experimental Autoimmune Diabetes | 0.6 | 102 | Citations (PDF) |
| 109 | Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans | 7.0 | 133 | Citations (PDF) |
| 110 | Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone | 8.1 | 94 | Citations (PDF) |
| 111 | Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host | 2.4 | 111 | Citations (PDF) |
| 112 | Bioactive Long-Term Release from Biodegradable Microspheres Preserves Implanted ALG-PLO-ALG Microcapsules from In Vivo Response to Purified Alginate | 3.9 | 13 | Citations (PDF) |
| 113 | Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis | 7.0 | 66 | Citations (PDF) |
| 114 | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease | 34.3 | 515 | Citations (PDF) |
| 115 | Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism | 1.5 | 57 | Citations (PDF) |
| 116 | IL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi | 0.6 | 112 | Citations (PDF) |
| 117 | SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis | 7.5 | 199 | Citations (PDF) |
| 118 | Melanoma presenting as circulating tumor cells associated with failed angiogenesis | 1.5 | 5 | Citations (PDF) |
| 119 | CTLA-4-immunoglobulin and indoleamine 2,3-dioxygenase in dominant tolerance 2008, , 87-106 | | 1 | Citations (PDF) |
| 120 | Functional yet Balanced Reactivity to <i>Candida albicans</i> Requires TRIF, MyD88, and IDO-Dependent Inhibition of <i>Rorc</i> | 0.6 | 166 | Citations (PDF) |
| 121 | Immunosuppression Via Tryptophan Catabolism: The Role of Kynurenine Pathway Enzymes | 0.8 | 95 | Citations (PDF) |
| 122 | Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy | 36.5 | 307 | Citations (PDF) |
| 123 | Innovative extraction procedure for obtaining high pure lycopene from tomato | 3.0 | 40 | Citations (PDF) |
| 124 | Receptors and Pathways in Innate Antifungal Immunity | 8.0 | 20 | Citations (PDF) |
| 125 | Tryptophan catabolism generates autoimmune-preventive regulatory T cells | 1.3 | 102 | Citations (PDF) |
| 126 | Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and toleranceBlood, 2006, 108, 2265-2274 | 1.0 | 176 | Citations (PDF) |
| 127 | Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokinesBlood, 2006, 107, 1039-1047 | 1.0 | 91 | Citations (PDF) |
| 128 | Toward the identification of a tolerogenic signature in IDO-competent dendritic cellsBlood, 2006, 107, 2846-2854 | 1.0 | 190 | Citations (PDF) |
| 129 | The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells | 0.6 | 996 | Citations (PDF) |
| 130 | Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO | 0.6 | 167 | Citations (PDF) |
| 131 | Immunity and Tolerance to <i>Aspergillus</i> Involve Functionally Distinct Regulatory T Cells and Tryptophan Catabolism | 0.6 | 194 | Citations (PDF) |
| 132 | The 2004 FASEB Summer Research Conference on Transplant Immunology: Closer to the Goal of Transplant-Specific Tolerance | 5.0 | 2 | Citations (PDF) |
| 133 | CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig | 2.4 | 24 | Citations (PDF) |
| 134 | Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells | 3.5 | 75 | Citations (PDF) |
| 135 | Immune-Reconstituted Influenza Virosome Containing <i>CD40L</i> Gene Enhances the Immunological and Protective Activity of a Carcinoembryonic Antigen Anticancer Vaccine | 0.6 | 19 | Citations (PDF) |
| 136 | A Crucial Role for Tryptophan Catabolism at the Host/<i>Candida albicans</i>Interface | 0.6 | 150 | Citations (PDF) |
| 137 | Cutting Edge: Silencing Suppressor of Cytokine Signaling 3 Expression in Dendritic Cells Turns CD28-Ig from Immune Adjuvant to Suppressant | 0.6 | 89 | Citations (PDF) |
| 138 | CTLA-4–Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice | 8.1 | 126 | Citations (PDF) |
| 139 | TLRs Govern Neutrophil Activity in Aspergillosis | 0.6 | 226 | Citations (PDF) |
| 140 | Murine Plasmacytoid Dendritic Cells Initiate the Immunosuppressive Pathway of Tryptophan Catabolism in Response to CD200 Receptor Engagement | 0.6 | 205 | Citations (PDF) |
| 141 | CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 | 24.9 | 276 | Citations (PDF) |
| 142 | TOLERANCE, DENDRITIC CELLS AND TRYPTOPHAN | 2.4 | 1 | Citations (PDF) |
| 143 | Modulation of tryptophan catabolism by regulatory T cells | 24.9 | 1,235 | Citations (PDF) |
| 144 | BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 | 24.9 | 821 | Citations (PDF) |
| 145 | Tolerance, DCs and tryptophan: much ado about IDO | 9.1 | 733 | Citations (PDF) |
| 146 | Response to von Bubnoff et al.: Still new perspectives on IDO function? | 9.1 | 0 | Citations (PDF) |
| 147 | Functional Plasticity of Dendritic Cell Subsets as Mediated by CD40 Versus B7 Activation | 0.6 | 101 | Citations (PDF) |
| 148 | A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice | 8.1 | 199 | Citations (PDF) |
| 149 | T Cell Apoptosis by Kynurenines | 8.0 | 182 | Citations (PDF) |
| 150 | Tryptophan Catabolism in Nonobese Diabetic Mice | 8.0 | 20 | Citations (PDF) |
| 151 | CD40 Ligand and CTLA-4 Are Reciprocally Regulated in the Th1 Cell Proliferative Response Sustained by CD8+ Dendritic Cells | 0.6 | 23 | Citations (PDF) |
| 152 | Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells | 3.5 | 234 | Citations (PDF) |
| 153 | IL-23 and IL-12 Have Overlapping, but Distinct, Effects on Murine Dendritic Cells | 0.6 | 222 | Citations (PDF) |
| 154 | T cell apoptosis by tryptophan catabolism | 13.8 | 935 | Citations (PDF) |
| 155 | CTLA-4–Ig regulates tryptophan catabolism in vivo | 24.9 | 1,100 | Citations (PDF) |
| 156 | Transplantation and the CD28/CTLA4/B7 pathway | 0.7 | 17 | Citations (PDF) |
| 157 | IL-6 Inhibits the Tolerogenic Function of CD8α+ Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase | 0.6 | 172 | Citations (PDF) |
| 158 | Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A | 3.5 | 48 | Citations (PDF) |
| 159 | CD40 Ligation Ablates the Tolerogenic Potential of Lymphoid Dendritic Cells | 0.6 | 131 | Citations (PDF) |
| 160 | Positive Regulatory Role of IL-12 in Macrophages and Modulation by IFN-γ | 0.6 | 119 | Citations (PDF) |
| 161 | Absence of CTLA-4 Lowers the Activation Threshold of Primed CD8+ TCR-Transgenic T Cells: Lack of Correlation with Src Homology Domain 2-Containing Protein Tyrosine Phosphatase | 0.6 | 50 | Citations (PDF) |
| 162 | Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice | 0.6 | 84 | Citations (PDF) |
| 163 | IFN-γ Inhibits Presentation of a Tumor/Self Peptide by CD8α− Dendritic Cells Via Potentiation of the CD8α+ Subset | 0.6 | 97 | Citations (PDF) |
| 164 | Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152) | 0.6 | 70 | Citations (PDF) |
| 165 | Th1 and Th2 Cell Clones to a Poorly Immunogenic Tumor Antigen Initiate CD8+ T Cell-Dependent Tumor Eradication In Vivo | 0.6 | 78 | Citations (PDF) |
| 166 | Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12 | 4.5 | 58 | Citations (PDF) |
| 167 | B7-1 Engagement of Cytotoxic T Lymphocyte Antigen 4 Inhibits T Cell Activation in the Absence of CD28 | 8.1 | 170 | Citations (PDF) |
| 168 | Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cells | 3.5 | 31 | Citations (PDF) |
| 169 | CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum− or helper peptides in priming for skin test reactivity to a P815AB-related peptide | 3.4 | 30 | Citations (PDF) |
| 170 | Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism | 1.6 | 107 | Citations (PDF) |
